We use some essential cookies to make this website work. These cookies are used to improve your website experience. To find out more about the cookies we use, see our Privacy Policy.
We’d also like to use analytics cookies so we can understand how you use the service and make improvements.
Use these toggles to accept or reject individual cookies. To find out more about the cookies we use, see our Privacy Policy.
We envision a future where cancer treatment for every patient is informed by accurate insights into their individual responses to existing and experimental therapies
Our mission is to enable personalisation of cancer treatment by providing advanced analytics tools for precise and accurate response predictions, in pre-clinical models and in patients
To maximise accuracy and precision of our predictions, we leverage advanced computational methods from astrophysics to integrate vast and complex research and real-world data to model human biology
Identify new drug indications and combinations using minimal data
Define patient-specific biomarkers of response to existing and emerging therapies
De-risk clinical drug development with in silico trials, digital twins and synthetic controls
Our cloud-based platform effectively integrates diverse data parcels to generate meaningful insights.
Translating advanced modelling and predictions using our unique technology for science and clinical research.
Our partners leverage Concr advanced predictive modelling across every stage of therapeutic development to create shared value for the benefit of cancer patients.
We teamed up with leading astrophysicists to adapt established algorithms for genuine integration of disparate oncology datasets.
We are a diverse group of world leaders and pioneers spanning three generations. We have been curated to answer the hardest questions in precision oncology translation and application.
If you’d like more information or have an enquiry, please contact us.
